With the current operating strategy for phase II they need 30-40 people with a UTI to recruit and be treated. Stratify them into different dosing regimes. Path tests of a few days after. Independent review panel review 3 months. All done inside 8 months.
Phase III studies are likely to be much bigger, but seriously if you have sepsis secondary to a UTI you are dying without prompt effective treatment. You will take the treatment. If you are alive 3 days later the treatment worked. No long follow up. Lets say recruitment takes a year you are still done inside 18 months.
On top of this they will need probably another 6-9 months for the FDA to agree on trial design. Still on track.
- Forums
- ASX - By Stock
- Ann: R327 added to WHO List of Antibacterial Products
With the current operating strategy for phase II they need 30-40...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
47.5¢ |
Change
0.015(3.26%) |
Mkt cap ! $102.0M |
Open | High | Low | Value | Volume |
46.0¢ | 47.5¢ | 46.0¢ | $27.74K | 59.52K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5365 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 24185 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5365 | 0.465 |
1 | 10101 | 0.460 |
6 | 193009 | 0.455 |
15 | 234856 | 0.450 |
2 | 112000 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 24125 | 5 |
0.475 | 56066 | 3 |
0.480 | 43723 | 3 |
0.485 | 84365 | 2 |
0.495 | 100000 | 1 |
Last trade - 11.34am 19/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |